S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.40 (+1.00%)
AAPL   177.95 (-1.55%)
MSFT   412.95 (-0.17%)
META   499.42 (+1.90%)
GOOGL   137.73 (-0.53%)
AMZN   178.00 (+0.70%)
TSLA   200.85 (-0.51%)
NVDA   819.42 (+3.58%)
NIO   5.83 (+1.39%)
AMD   200.00 (+3.88%)
BABA   74.98 (+1.28%)
T   16.94 (+0.06%)
F   12.49 (+0.40%)
MU   95.41 (+5.30%)
CGC   3.27 (-0.61%)
GE   158.85 (+1.25%)
DIS   111.55 (-0.03%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.41 (+0.12%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.40 (+1.00%)
AAPL   177.95 (-1.55%)
MSFT   412.95 (-0.17%)
META   499.42 (+1.90%)
GOOGL   137.73 (-0.53%)
AMZN   178.00 (+0.70%)
TSLA   200.85 (-0.51%)
NVDA   819.42 (+3.58%)
NIO   5.83 (+1.39%)
AMD   200.00 (+3.88%)
BABA   74.98 (+1.28%)
T   16.94 (+0.06%)
F   12.49 (+0.40%)
MU   95.41 (+5.30%)
CGC   3.27 (-0.61%)
GE   158.85 (+1.25%)
DIS   111.55 (-0.03%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.41 (+0.12%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.40 (+1.00%)
AAPL   177.95 (-1.55%)
MSFT   412.95 (-0.17%)
META   499.42 (+1.90%)
GOOGL   137.73 (-0.53%)
AMZN   178.00 (+0.70%)
TSLA   200.85 (-0.51%)
NVDA   819.42 (+3.58%)
NIO   5.83 (+1.39%)
AMD   200.00 (+3.88%)
BABA   74.98 (+1.28%)
T   16.94 (+0.06%)
F   12.49 (+0.40%)
MU   95.41 (+5.30%)
CGC   3.27 (-0.61%)
GE   158.85 (+1.25%)
DIS   111.55 (-0.03%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.41 (+0.12%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.40 (+1.00%)
AAPL   177.95 (-1.55%)
MSFT   412.95 (-0.17%)
META   499.42 (+1.90%)
GOOGL   137.73 (-0.53%)
AMZN   178.00 (+0.70%)
TSLA   200.85 (-0.51%)
NVDA   819.42 (+3.58%)
NIO   5.83 (+1.39%)
AMD   200.00 (+3.88%)
BABA   74.98 (+1.28%)
T   16.94 (+0.06%)
F   12.49 (+0.40%)
MU   95.41 (+5.30%)
CGC   3.27 (-0.61%)
GE   158.85 (+1.25%)
DIS   111.55 (-0.03%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.41 (+0.12%)
XOM   106.31 (+1.71%)

iRhythm Technologies (IRTC) Stock Price, News & Analysis

$120.59
+1.94 (+1.64%)
(As of 11:48 AM ET)
Today's Range
$116.13
$120.96
50-Day Range
$100.25
$123.61
52-Week Range
$70.24
$140.23
Volume
62,469 shs
Average Volume
338,782 shs
Market Capitalization
$3.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$135.11

iRhythm Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
11.8% Upside
$135.11 Price Target
Short Interest
Healthy
4.03% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.26mentions of iRhythm Technologies in the last 14 days
Based on 39 Articles This Week
Insider Trading
Selling Shares
$745,692 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.14) to ($1.98) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.25 out of 5 stars

Medical Sector

607th out of 957 stocks

Surgical & Medical Instruments Industry

69th out of 98 stocks


IRTC stock logo

About iRhythm Technologies Stock (NASDAQ:IRTC)

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Stock Price History

IRTC Stock News Headlines

Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
iRhythm Shareholder Notice
IRTC Jun 2024 60.000 put
Irhythm Technologies: Poised for Growth Despite Challenges
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
3/01/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$135.11
High Stock Price Target
$165.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+13.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-123,410,000.00
Pretax Margin
-24.90%

Debt

Sales & Book Value

Annual Sales
$492.68 million
Book Value
$6.78 per share

Miscellaneous

Free Float
30,846,000
Market Cap
$3.69 billion
Optionable
Optionable
Beta
1.33
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report














IRTC Stock Analysis - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price target for 2024?

8 Wall Street analysts have issued 12 month price objectives for iRhythm Technologies' shares. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's share price to reach $135.11 in the next year. This suggests a possible upside of 11.8% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2024?

iRhythm Technologies' stock was trading at $107.04 on January 1st, 2024. Since then, IRTC stock has increased by 12.9% and is now trading at $120.88.
View the best growth stocks for 2024 here
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.81) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.09) by $0.28. The firm had revenue of $85.43 million for the quarter, compared to the consensus estimate of $83.65 million. iRhythm Technologies had a negative net margin of 25.05% and a negative trailing twelve-month return on equity of 56.38%. The business's quarterly revenue was up 18.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.17) earnings per share.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.77%), Capital Research Global Investors (8.14%), Sands Capital Management LLC (7.30%), Artisan Partners Limited Partnership (6.76%), Mackenzie Financial Corp (4.13%) and Fiera Capital Corp (1.30%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRTC) was last updated on 3/1/2024 by MarketBeat.com Staff